Literature DB >> 10707970

Neuropilin-2 is required in vivo for selective axon guidance responses to secreted semaphorins.

R J Giger1, J F Cloutier, A Sahay, R K Prinjha, D V Levengood, S E Moore, S Pickering, D Simmons, S Rastan, F S Walsh, A L Kolodkin, D D Ginty, M Geppert.   

Abstract

Neuropilins are receptors for class 3 secreted semaphorins, most of which can function as potent repulsive axon guidance cues. We have generated mice with a targeted deletion in the neuropilin-2 (Npn-2) locus. Many Npn-2 mutant mice are viable into adulthood, allowing us to assess the role of Npn-2 in axon guidance events throughout neural development. Npn-2 is required for the organization and fasciculation of several cranial nerves and spinal nerves. In addition, several major fiber tracts in the brains of adult mutant mice are either severely disorganized or missing. Our results show that Npn-2 is a selective receptor for class 3 semaphorins in vivo and that Npn-1 and Npn-2 are required for development of an overlapping but distinct set of CNS and PNS projections.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10707970     DOI: 10.1016/s0896-6273(00)80869-7

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  121 in total

1.  Semaphorin 3A is required for guidance of olfactory axons in mice.

Authors:  G A Schwarting; C Kostek; N Ahmad; C Dibble; L Pays; A W Püschel
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 2.  Cellular and molecular mechanisms of embryonic haemangiogenesis and lymphangiogenesis.

Authors:  Jörg Wilting; Bodo Christ; Li Yuan; Anne Eichmann
Journal:  Naturwissenschaften       Date:  2003-09-17

Review 3.  Turning heads: development of vertebrate branchiomotor neurons.

Authors:  Anand Chandrasekhar
Journal:  Dev Dyn       Date:  2004-01       Impact factor: 3.780

4.  Congenital CNS hypomyelination in the Fig4 null mouse is rescued by neuronal expression of the PI(3,5)P(2) phosphatase Fig4.

Authors:  Jesse J Winters; Cole J Ferguson; Guy M Lenk; Vessela I Giger-Mateeva; Peter Shrager; Miriam H Meisler; Roman J Giger
Journal:  J Neurosci       Date:  2011-11-30       Impact factor: 6.167

5.  Expression by midbrain dopamine neurons of Sema3A and 3F receptors is associated with chemorepulsion in vitro but a mild in vivo phenotype.

Authors:  Enrique R Torre; Claire-Anne Gutekunst; Robert E Gross
Journal:  Mol Cell Neurosci       Date:  2010-03-16       Impact factor: 4.314

6.  Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation.

Authors:  Karine Bouvrée; Isabelle Brunet; Raquel Del Toro; Emma Gordon; Claudia Prahst; Brunella Cristofaro; Thomas Mathivet; Yunling Xu; Jihane Soueid; Vitor Fortuna; Nayoki Miura; Marie-Stéphane Aigrot; Charlotte H Maden; Christiana Ruhrberg; Jean Léon Thomas; Anne Eichmann
Journal:  Circ Res       Date:  2012-06-21       Impact factor: 17.367

7.  Inactivation of the Sema5a gene results in embryonic lethality and defective remodeling of the cranial vascular system.

Authors:  Roberto Fiore; Belquis Rahim; Vincent M Christoffels; Antoon F M Moorman; Andreas W Püschel
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

8.  Inflammation and Lymphedema Are Exacerbated and Prolonged by Neuropilin 2 Deficiency.

Authors:  Patrick Mucka; Nicholas Levonyak; Elena Geretti; Bernadette M M Zwaans; Xiaoran Li; Irit Adini; Michael Klagsbrun; Rosalyn M Adam; Diane R Bielenberg
Journal:  Am J Pathol       Date:  2016-10-14       Impact factor: 4.307

9.  Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding.

Authors:  Brent A Appleton; Ping Wu; Janice Maloney; JianPing Yin; Wei-Ching Liang; Scott Stawicki; Kyle Mortara; Krista K Bowman; J Michael Elliott; William Desmarais; J Fernando Bazan; Anil Bagri; Marc Tessier-Lavigne; Alexander W Koch; Yan Wu; Ryan J Watts; Christian Wiesmann
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

10.  Brn3a and Nurr1 mediate a gene regulatory pathway for habenula development.

Authors:  Lely A Quina; Shirong Wang; Lydia Ng; Eric E Turner
Journal:  J Neurosci       Date:  2009-11-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.